In just one year, the healthcare supply chain leader achieves 80% YoY growth, ₹582 crore (including GMV) topline in Q2, and turns EBITDA positive through disciplined execution and strategic realignment.One year ago, Medikabazaar embarked on a strategic path of hypergrowth with a clear focus on profitability.
In a strategic move to expand its footprint in the paediatric and wellness segment, Cipla Limited has announced the acquisition of Inzpera Healthsciences Ltd for ₹110.65 crore.The acquisition underscores Cipla’s continued focus on diversified consumer healthcare solutions, particularly in the areas of child nutrition, gut
